Table 1.
Patient characteristics.
Figure 1.
Height gain SDS during 3 years of MP treatment.
Data are expressed as model estimates (standard error), ≥1 yr use of MP in 36 subjects, ≥2 yrs n = 26 and ≥3 yrs n = 20. GH = growth hormone; MP = methylphenidate; SGA = small for gestational age; SDS = standard deviation score.
Figure 2.
IGF-I, IGFBP-3 and IGF-I/IGFBP-3 ratio gain SDS values during 3 years of MP treatment.
Data are expressed as model estimates (standard error). IGF-I = insulin-like growth factor; IGFBP-3 = insulin-like growth factor binding protein-3; MP = methylphenidate; SGA = small for gestational age; SDS = standard deviation score.